Browse study websites

Discover. Prevent. Cure.

Menu Fundraise Donate

    Recommended pages

      Do you mean

        31-40 of 237 results for 'RSV'

        Refine search

        Research

        Potential impact of a maternal vaccine for RSV: A mathematical modelling study

        Respiratory syncytial virus is a major cause of respiratory morbidity and one of the main causes of hospitalisation in young children. ...

        Research

        High burden of RSV hospitalization in very young children: a data linkage study

        RSV was associated with substantial burden of childhood hospitalization specifically in children aged <3 months and in Indigenous children and pre-term children ...

        News & Events

        RSV responsible for one out of every 50 childhood deaths worldwide

        The urgency for a world-first respiratory syncytial virus vaccine is at an all-time high. ...

        News & Events

        Study finds high RSV awareness with parents open to future immunisation

        A Telethon Kids Institute study designed to gauge community awareness of respiratory syncytial virus (RSV) has found parents and parents-to-be are highly aware of the virus and are open to immunisation to tackle it. ...

        News & Events

        Research to explore promising new RSV treatment supported by innovation seed funding

        Researchers from the Wal-yan Respiratory Research Centre are collaborating with Virex Pharma to undertake vital research into a potential breakthrough treatment for RSV infections in young children, thanks to a $499,241 grant awarded by the WA Department of Health Innovation Seed Fund. ...

        News & Events

        Research into chronic lung disease in Indigenous children and a novel RSV treatment boosted thanks to WACRF grants

        Wal-yan Respiratory Research Centre researchers will use almost $1.2 million in WA Child Research Fund grants to determine why Indigenous children develop bronchiectasis at such high rates after contracting bronchiolitis, and to test a promising novel treatment for respiratory syncytial virus (RSV). ...

        Research

        Characterising the epidemiology of RSV in Australian children through record linkage: clinical burden, outcomes and risk factors

        Hannah Peter Moore Richmond HC PC OAM BSc (Hons) GradDipClinEpi PhD MBBS MRCP(UK) FRACP Program Head, Infection and Vaccines Head, Vaccine Trials ...

        Research

        Risk factors associated with RSV hospitalisation in the first 2 years of life, among different subgroups of children in NSW

        Data on risk factors for respiratory syncytial virus (RSV)-associated hospitalisation in Australian children may be informative for preventive measures. ...

        Research

        A phase 3, randomized, double-blinded, placebo-controlled trial toevaluate the efficacy and safety of a respiratory syncytial virus (RSV) prefusion F subunit vaccine in infants born to women vaccinated during pregnancy (Matisse)

        Peter Richmond PC MBBS MRCP(UK) FRACP Head, Vaccine Trials Group Head, Vaccine Trials Group Professor Peter Richmond is Head of the Vaccine Trials ...

        Research

        A Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine with Aluminium in Healthy Third-trimester Pregnant Women; and Safety

        Elke Jennifer Peter Seppanen Kent Richmond ES J PC BSc PhD RN MBBS MRCP(UK) FRACP Program Manager, Bacterial Respiratory Infectious Disease Group ...

        Page 4 of 24